Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-09-09 00:00:00 ET · period of report 2024-09-09 · accession 0001127602-24-023646 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-09 | 2024-09-09 | CYTK | PARSHALL B LYNNE | Dir | S - Sale+OE | $54.92 | -5,000 | 20.6K | -20% | -$274.6K |
| D | 2024-09-09 | 2024-09-09 | CYTK | PARSHALL B LYNNE | Dir | M - OptEx | $21.61 | +5,000 | 25.6K | +24% | +$108.0K |
| D | 2024-09-09 | 2024-09-09 | CYTK | PARSHALL B LYNNE | Dir | M - OptEx | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-09 | S | D | 5,000 | $54.92 | 20,600 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-09 | M | A | 5,000 | $21.61 | 25,600 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-09-09 | M | D | 5,000 | $0.00 | 0 | D | $21.61 · — to 2030-05-13 | 5,000 Common Stock | (F1) Options shall vest and become exercisable in 12 equal monthly installments as from the date of the grant. |